Margaret Frame
How do cancer cells spread - and how can we stop them?
University of Edinburgh
Western General Hospital
Crewe Road South
Edinburgh
EH4 2XR
United Kingdom
Email: m.frame@ed.ac.uk
Tel: 01317773500
Web: Lab website
Professor Margaret Frame and her team at University of Edinburgh are tackling one of the biggest challenges in cancer treatment - how to stop the disease spreading to other parts of the body. The researchers are investigating how cancer cells break away from a tumour and start moving, to find out how this process could be stopped.
Cells on the move
Cell movement is controlled by a number of different proteins - molecules inside cells that send messages telling cells to move or stay put.
Professor Frame is internationally recognised for her groundbreaking research on two 'messenger' proteins called Src and FAK, which play important roles in cell movement and are implicated in cancer spread. These proteins are overactive in cancer cells, sending too many messages that encourage the cells to move and spread.
Professor Frame's team are studying how Src and FAK work in healthy cells and in cancer. They are investigating how signals from these proteins make cells stick to each other or break apart, and how they become overactive in cancer.
Stopping cancer in its tracks
By understanding how these overactive proteins control the movement and spread of cancer cells, Professor Frame and her team hope to discover new ways to target cancer cells and develop new drugs to treat the disease.
Finding ways to block the messages coming from Src and FAK could halt the spread of cancer, providing powerful ways to treat the disease in the future.
Visit MyProjects to donate directly to Professor Frame's research.
Other research projects by Margaret Frame
Biological Sciences Committee (BSC) Programme Grants
Funding period: 01 January 2008 to 30 April 2013
Biological Sciences Committee (BSC) Programme Grants
Funding period: 01 March 2010 to 28 February 2013
Publications
Quantitative In vivo Imaging of the Effects of Inhibiting Integrin Signaling via Src and FAK on Cancer Cell Movement: Effects on E-cadherin Dynamics
Cancer Res.2010;70 :9413-9422
beta 1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression
Proc Natl Acad Sci U S A.2010;107 :15559-15564






Read press release 